Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.55 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.50 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.45 |
| ▸ | FDPS | P14324 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | PPARD | Q03181 | 1/20 | 0.44 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.44 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4434924 | 1.00 | CA1 (0.55) | CA1ACE2ZDHHC7FAAHFFAR1 | |
| SCHEMBL5935426 | 1.00 | CA1 (0.55) | CA1ACE2ZDHHC7FAAHFFAR1 | |
| SCHEMBL28112995 | 1.00 | CA1 (0.55) | CA1ACE2ZDHHC7FAAHFFAR1 | |
| SCHEMBL8573656 | 1.00 | CA1 (0.55) | CA1ACE2ZDHHC7FAAHFFAR1 | |
| Methane SCHEMBL669000 | 0.98 | CA1 (0.53) | CA1ACE2ZDHHC7FAAHFFAR1 | |
| SCHEMBL11043736 | 0.98 | CA1 (0.57) | CA1ACE2ZDHHC7FAAHFFAR1 | |
| SCHEMBL7804736 | 0.91 | CA1 (0.48) | CA1ACE2ZDHHC7FDPSMAPT | |
| Methyl Alcohol SCHEMBL14895152 | 0.88 | FAAH (0.46) | FAAHFFAR1FFAR4MAPTPPARD | |
| SCHEMBL8994069 | 0.85 | CA1 (0.57) | CA1ACE2ZDHHC7FAAHFFAR1 | |
| SCHEMBL8052116 | 0.85 | CA1 (0.57) | CA1ACE2ZDHHC7FAAHFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009158633-A1 | DRUG CONJUGATES | CURATORS OF THE UNIVERSITY OF MISSOURI ON BEHALF OF THE UNIVERSITY OF MISSOURI-KANSAS CITY (US) | 2009-12-30 | — | — | WO | disclosed |
| US-20050154221-A1 | Integrate chemical processes for industrial utilization of seed oils | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION | 2005-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050154221-A1 | Integrate chemical processes for industrial utilization of seed oils | ALOX12, SQLE, ALOX15 | CA1 3252/4885ACE2 3087/4885ZDHHC7 596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.